Skip to main content
. 2015 Oct 10;7(10):4067–4082. doi: 10.3390/toxins7104067

Figure 7.

Figure 7

The effect of treatment of established PC-3 flank tumors with dDTEGF13. (A) Nude mice bearing PC-3 flank tumors were treated intratumorally with dDTEGF13, control DT2219ARL, or untreated. Tumors were treated with 8 injections of dDTEGF13. Average tumor volumes are shown for each treatment group (* = P < 0.004; # = P < 0.05); (B) Individual tumor volumes are shown for both the irrelevant control BLT treated group (DT2219ARL) and the untreated mice. The growth of individual tumors is plotted over time.